-
Mashup Score: 12
Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations a
Source: www.ahajournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study - 3 day(s) ago
Patients treated for hypertension while taking ibrutinib benefit from combination therapy.Regimens that combine HCTZ and β blockers benefit patients with p
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1515 Herramientas para gestionar tu Marca Personal por tareas - 3 day(s) ago
Potencia tu Marca Personal en Internet con estas herramientas para gestionar tu estrategia de personal branding por tareas.
Source: claudioinacio.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Guía MODELOS DE ATENCIÓN MULTIDISCIPLINAR EN LINFOMAS. Comité de Linfomas - Unidad Funcional de Linfomas 2024 - 3 day(s) ago
Coordinación : Dra. Eva González Barca Estado: Nueva publicación 2024 DESCARGAR DOCUMENTO
Source: www.geltamo.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17Guía MODELOS DE ATENCIÓN MULTIDISCIPLINAR EN LINFOMAS. Comité de Linfomas - Unidad Funcional de Linfomas 2024 - 4 day(s) ago
Coordinación : Dra. Eva González Barca Estado: Nueva publicación 2024 DESCARGAR DOCUMENTO
Source: www.geltamo.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas - 9 day(s) ago
For more than 70 years, glucocorticoids have been known to have clinical activity against lymphoid but not myeloid malignancies. Choi et al. resolve this conundrum by demonstrating that glucocorticoids kill lymphomas by inhibiting BCR signaling. These mechanistic insights enable rational combination of glucocorticoids with other targeted agents in anti-lymphoma regimens.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 43Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis - 11 day(s) ago
Key Points. CAR-T cell therapy demonstrates superior efficacy to bispecific antibody in DLBCL treatment, with higher complete response rates.CAR-T cell the
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Analysis of @DrRaulCordoba FOLLOWERS - 12 day(s) ago
Mis seguidores viven en España(45%),Estados Unidos(22%),UK.(6%) y más tweepsmap.com/!DrRaulCordoba
Source: fedica.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 40Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis - 14 day(s) ago
Key Points. CAR-T cell therapy demonstrates superior efficacy to bispecific antibody in DLBCL treatment, with higher complete response rates.CAR-T cell the
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study - 15 day(s) ago
Chimeric Antigen Receptor-T (CAR-T) cell infusion is a rapidly evolving antitumor therapy; however, cardiovascular (CV) complications, likely associated with cytokine release syndrome (CRS) and systemic inflammation, have been reported to occur. The CARdio-Tox …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
#Hematology Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the @American_Heart Association | @CircAHA #CardioOnc #bmtsm #survonc https://t.co/p0KcOHwiIY